Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sunshine Lake Pharma Co's Enterprise Value is HK$33,362 Mil.
Sunshine Lake Pharma Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$737 Mil. Therefore, Sunshine Lake Pharma Co's EV-to-EBIT ratio for today is 45.24.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Sunshine Lake Pharma Co (HKSE:06887) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sunshine Lake Pharma Co's current Enterprise Value is HK$33,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sunshine Lake Pharma Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$737 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sunshine Lake Pharma Co's EV-to-EBITDA for today is:
Sunshine Lake Pharma Co's current Enterprise Value is HK$33,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sunshine Lake Pharma Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$737 Mil.
Sunshine Lake Pharma Co's current Enterprise Value is HK$33,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sunshine Lake Pharma Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$5,297 Mil.
Sunshine Lake Pharma Co's current Enterprise Value is HK$33,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sunshine Lake Pharma Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1,276 Mil.
Sunshine Lake Pharma Co's current Enterprise Value is HK$33,362 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sunshine Lake Pharma Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$261 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Lake Pharma Co Enterprise Value Related Terms
Sunshine Lake Pharma Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Lake Pharma Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Lake Pharma Co Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sunshine Lake Pharma Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sunshine Lake Pharma Co's Enterprise Value falls into.
Sunshine Lake Pharma Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sunshine Lake Pharma Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$33,362 Mil mean?
Sunshine Lake Pharma Co (HKSE:06887) has a Enterprise Value of HK$33,362 Mil as of Aug. 21, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sunshine Lake Pharma Co and its competitors.
Is Sunshine Lake Pharma Co's Enterprise Value too high?
Sunshine Lake Pharma Co's current Enterprise Value is HK$33,362 Mil. Overall, Sunshine Lake Pharma Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sunshine Lake Pharma Co's Enterprise Value compare to ZTS?
Sunshine Lake Pharma Co's Enterprise Value of HK$33,362 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sunshine Lake Pharma Co and its competitors. Sunshine Lake Pharma Co's current Enterprise Value is HK$33,362 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Lake Pharma Co stock overvalued right now?
Sunshine Lake Pharma Co (HKSE:06887) has a current Enterprise Value of HK$33,362 Mil. The current Enterprise Value is HK$33,362 Mil. Sunshine Lake Pharma Co's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Sunshine Lake Pharma Co (HKSE:06887), the current Enterprise Value is HK$33,362 Mil as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
15GF Score
Get the complete analysis for HKSE:06887
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06887 has been successfully added to your 
